Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: Defence Therapeutics Inc.: DEFENCE REPORTS EFFECTIVE CONTROL OF CERVICAL CANCER GROWTH IN RESPONSE TO ITS ACCUVAC-PT007 THERAPEUTIC VACCINATION
DGAP-News: Defence Therapeutics Inc.: DEFENCE REPORTS EFFECTIVE CONTROL OF CERVICAL CANCER GROWTH IN RESPONSE TO ITS ACCUVAC-PT007 THERAPEUTIC VACCINATION
DGAP-News: Defence Therapeutics Inc.: DEFENCE REPORTS EFFECTIVE CONTROL OF CERVICAL CANCER GROWTH IN RESPONSE TO ITS ACCUVAC-PT007 THERAPEUTIC VACCINATION
Genel Energy PLC: Receipt of payments for KRI oil sales
Genel Energy PLC: Receipt of payments for KRI oil sales
Genel Energy PLC: Receipt of payments for KRI oil sales
DKSH Performance Materials Strengthens its Life Sciences Capabilities by Acquiring Refarmed Group
DKSH Performance Materials Strengthens its Life Sciences Capabilities by Acquiring Refarmed Group
DKSH Performance Materials Strengthens its Life Sciences Capabilities by Acquiring Refarmed Group
Achiko AG Announces Annual Results for the Year Ended 31 December 2021
Achiko AG Announces Annual Results for the Year Ended 31 December 2021
Achiko AG Announces Annual Results for the Year Ended 31 December 2021
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicronhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 Vaccine Candidates Demonstrate High Immune Response Against Omicron


Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive data evaluating the safety, tolerability, and immunogenicity of two Omicron-adapted COVID-19 vaccine candidates: one

DGAP-Adhoc: MagForce AG issues Bearer Notes with a total Volume of up to EUR 3.5 Million to Lansdowne Investment Company Cyprus Limited
DGAP-Adhoc: MagForce AG issues Bearer Notes with a total Volume of up to EUR 3.5 Million to Lansdowne Investment Company Cyprus Limited
DGAP-Adhoc: MagForce AG issues Bearer Notes with a total Volume of up to EUR 3.5 Million to Lansdowne Investment Company Cyprus Limited
DGAP-News: Pacifico Renewables Yield AG combines strong growth and profitability in financial year 2021 – further revenue growth continues
DGAP-News: Pacifico Renewables Yield AG combines strong growth and profitability in financial year 2021 – further revenue growth continues
DGAP-News: Pacifico Renewables Yield AG combines strong growth and profitability in financial year 2021 – further revenue growth continues
DGAP-News: Adler Group S.A. sells portfolio in Berlin to ADLER Real Estate AG
DGAP-News: Adler Group S.A. sells portfolio in Berlin to ADLER Real Estate AG
DGAP-News: Adler Group S.A. sells portfolio in Berlin to ADLER Real Estate AG
Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analystshttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Invites Public to View and Listen to Webcast of July 28 Conference Call with Analysts


Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Thursday, July 28, 2022. The purpose

DGAP-Adhoc: Allterco JSCo announces intention to repurchase own shares through over-the-counter transactions
DGAP-Adhoc: Allterco JSCo announces intention to repurchase own shares through over-the-counter transactions
DGAP-Adhoc: Allterco JSCo announces intention to repurchase own shares through over-the-counter transactions
Landis+Gyr Shareholders Approve all Proposals
Landis+Gyr Shareholders Approve all Proposals
Landis+Gyr Shareholders Approve all Proposals
Investis acquires Home Service AG, Zurich
Investis acquires Home Service AG, Zurich
Investis acquires Home Service AG, Zurich
Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding
William P. Foley, II, Cannae Holdings, Inc. and Other Third-Party Investors Intend to Invest in John Textor’s Eagle Football
William P. Foley, II, Cannae Holdings, Inc. and Other Third-Party Investors Intend to Invest in John Textor’s Eagle Football


Cannae Holdings, Inc. (NYSE: CNNE) (“Cannae” or the “Company”) has signed a non-binding letter of intent to invest in John Textor’s Eagle Football Holdings LLC (“Eagle Football” or “Eagle”)

U.S. Retailers Meet Online Demand With Unified Experiences: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
U.S. Retailers Meet Online Demand With Unified Experiences


Retailers in the U.S. are responding to a massive shift toward online shopping by integrating different sales and marketing systems for a seamless customer experience, according to a new research

EQS Group (EQS): Regulatory stimulus set for H222
EQS Group (EQS): Regulatory stimulus set for H222
EQS Group (EQS): Regulatory stimulus set for H222
Yard Works Joins SiteOne Landscape Supply: https://mms.businesswire.com/media/20200803005764/en/810030/5/SITE-Logo.jpg
Yard Works Joins SiteOne Landscape Supply


SiteOne® Landscape Supply, Inc. (NYSE: SITE) announced today the company completed its acquisition of Yard Works, LLC (“Yard Works”), a wholesale distributor of bulk landscape supplies with 13

CarMax Reports First Quarter Fiscal 2023 Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24307/375px-CarMax_Logo.svg.png
CarMax Reports First Quarter Fiscal 2023 Results


CarMax, Inc. (NYSE:KMX) today reported results for the first quarter ended May 31, 2022.



Highlights:




  • Enabled online self-progression capabilities for all of our retail customers


  • Net

DGAP-Adhoc: FYB201, Formycon's biosimilar for Lucentis® (ranibizumab), receives CHMP recommendation from EMA
DGAP-Adhoc: FYB201, Formycon's biosimilar for Lucentis® (ranibizumab), receives CHMP recommendation from EMA
DGAP-Adhoc: FYB201, Formycon's biosimilar for Lucentis® (ranibizumab), receives CHMP recommendation from EMA
WICKES GROUP PLC: Director / PDMR Shareholding
WICKES GROUP PLC: Director / PDMR Shareholding
WICKES GROUP PLC: Director / PDMR Shareholding
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
DGAP-News: wallstreet:online AG: Annual General Meeting resolves to change the company name / Management Board presents “Case Study 2026”
DGAP-News: wallstreet:online AG: Annual General Meeting resolves to change the company name / Management Board presents “Case Study 2026”
DGAP-News: wallstreet:online AG: Annual General Meeting resolves to change the company name / Management Board presents “Case Study 2026”
Europe Catching Up to Retail Technology Revolution: https://mms.businesswire.com/media/20210201005142/en/1016900/5/ISG_%28R%29_Logo.jpg
Europe Catching Up to Retail Technology Revolution


European retailers are modernizing their IT capabilities to adapt to changing consumer behavior in the wake of the COVID-19 pandemic, but still lag behind retailers in the U.S. and other markets

DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad invests in the Series B  funding of HR-Tech company WorkMotion
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad invests in the Series B funding of HR-Tech company WorkMotion
DGAP-News: Heliad Equity Partners GmbH & Co. KGaA: Heliad invests in the Series B funding of HR-Tech company WorkMotion